Navigation Links
SGX Pharmaceuticals Announces First Quarter Financial Results and Gives Pipeline Update
Date:5/13/2008

e hereof.

SGX PHARMACEUTICALS, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data)

(unaudited)

Three Months Ended

March 31,

2008 2007

Revenue:

Collaborations and

commercial agreements $15,001 $5,647

Grants 1,971 5,321

Total revenue 16,972 10,968

Operating expenses:

Research and development 11,349 10,018

General and administrative 2,121 2,233

Total operating expenses 13,470 12,251

Income (loss) from operations 3,502 (1,283)

Interest income and expense, net 219 185

Net income (loss) $3,721 $(1,098)

Net income (loss) per common share:

Basic $0.18 $(0.07)

Diluted $0.18 $(0.07)

Shares used to compute

basic and diluted net

income (loss) per common share:

Basic 20,530 15,228

Diluted 21,089 15,228

Three Months Ended Three Months Ended

March 31, 2008 (1) March 31, 2007 (1)

Stock- Stock-

based Reported based Reported

compensation GAAP compensation GAAP

non-GAAP expense results non-GAAP expense results

Net income (loss) $4,347 $(626) $3,721 $(109) $(989) $(1,098)

Basic net income

(loss) per common

share:
'/>"/>

SOURCE SGX Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
5. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
6. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
7. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
8. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
9. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
10. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
11. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... 3, 2015 ... osoitteessa  http://www.openinnovationinscience.at Wienissä pidettävään ... Science" -jatkokoulutusohjelmaan 22.7.2015 asti.  ... tekemän, kansainvälisiä tutkijoita ja tiedemiehiä ... suurinta haastetta ovat kannustimien puute ...
(Date:7/3/2015)... 3, 2015 Forskare ... 2015 på  http://www.openinnovationinscience.at till det återkommande ... som hålls i Wien ... med internationella forskare och vetenskapsmän som genomfördes ... två största utmaningar bristen på incitament för ...
(Date:7/3/2015)... , July 3, 2015 ... 22. september 2015 på  http://www.openinnovationinscience.at om ... der finder sted i Wien ... undersøgelse af internationale forskere og videnskabsmænd foretaget ... to største udfordringer for sundhedsvidenskaben manglen på ...
(Date:7/2/2015)... , July 2, 2015  Spherix Incorporated (Nasdaq: ... fostering and monetization of intellectual property, today announced a ... Spherix Incorporated v. Verizon Services Corp. et al. , ... for the Eastern District of Virginia ... 1, 2015 interpreting certain key claims in favor of ...
Breaking Biology Technology:Maailman ensimmäinen tiedemiesten koulutukseen suunniteltu avoimen innovaation ohjelma käynnistyy 2Maailman ensimmäinen tiedemiesten koulutukseen suunniteltu avoimen innovaation ohjelma käynnistyy 3Lansering av världens första program för öppen innovation för att utbilda forskare 2Lansering av världens första program för öppen innovation för att utbilda forskare 3Lancering af verdens første åbne innovationsprogram til uddannelse af forskere 2Lancering af verdens første åbne innovationsprogram til uddannelse af forskere 3Spherix Issues A Litigation Update 2Spherix Issues A Litigation Update 3
... Planting Season, BEIJING and CLAREMONT, Calif., May ... Bulletin Board: KWBT),announced revenues for the first quarter ... of 57.8% above revenues of $1,384,093 for the ... is due to the expansion in Kiwa,s,bio-fertilizer and ...
... ... EDMONTON, May 9 /PRNewswire-FirstCall/ - BioMS Medical Corp (TSX: MS),a leading ... on its pipeline products, HYC750 and development with,BioCyDex Inc., The ... Inc. for HYC750, a technology based on hyaluronic acid that,has a ...
... Institute Offers Tips for Coping with the Holiday, ... millions of women coping with infertility, which affects,at least ... Mother,s Day,",says Phyllis Martin, a therapist affiliated with the ... treatment center,based in Fairfax, VA. "Women who are distressed ...
Cached Biology Technology:Kiwa Bio-Tech 1st Quarter Revenues Increase 57.8% - $2.18 Million 2Kiwa Bio-Tech 1st Quarter Revenues Increase 57.8% - $2.18 Million 3BioMS Medical Provides Update On Pipeline Products 2BioMS Medical Provides Update On Pipeline Products 3Mother's Day is Devastating for Women Facing Infertility 2
(Date:6/23/2015)... June 23, 2015  Crossmatch™, a leading ... today announced enhanced functionality of its DigitalPersona ... The enhancements build on the native flexibility ... Altus platform and provide expanded mobile credential ... In today,s environment of increasing cyber-attacks and ...
(Date:6/18/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company") ... market announces that its Wocket® smart wallet will be the ... scheduled to air on WABC Radio (am770) in ... The broadcast air- time for the extensive one ... Inc.,s CEO Gino Pereira will be discussing its ...
(Date:6/17/2015)... , and HILDEN, Germany , June ... QGEN ; Frankfurt Prime Standard: QIA) today launched new Investigator ... in forensic laboratories in the United States ... to simultaneously analyze multiple key genomic markers (short tandem repeats ... Quality Sensor to evaluate the quality of DNA in ...
Breaking Biology News(10 mins):Crossmatch Releases Enhanced DigitalPersona Altus Advanced Authentication Functionality 2NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 2NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 3QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 2QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 3QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 4QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 5
... whales in Stellwagen Bank National Marine Sanctuary reveals ... the seafloor. Rather than a single bottom feeding ... simple side-rolls, side-roll inversions, and repetitive scooping. ... Marine Mammal Science , indicates that bottom side-roll ...
... research group at the University of Helsinki and Folkhlsan ... causing chondrodysplasia in two dog breeds, the Norwegian Elkhound ... new chondrodysplasia gene in dogs, and a candidate gene ... biology as well as canine health. A genetic test ...
... devastating disease Huonglongbing, or citrus greening, looms darkly over ... citrus industry, whose fresh fruit alone was valued at ... a research team led by a University of California, ... a broad picture of how citrus greening impacts trees ...
Cached Biology News:Research reveals bottom feeding techniques of tagged humpback whales in Stellwagen Bank Sanctuary 2Research reveals bottom feeding techniques of tagged humpback whales in Stellwagen Bank Sanctuary 3New dwarfism mutation identified in dogs 2New study offers hope for halting incurable citrus disease 2New study offers hope for halting incurable citrus disease 3
Reusble. Uses in conjunction with the Apoptotic Cell Isolation Kit....
ANTI K. AEROGENES...
GOAT ANTI FRK...
... Spots and complementary RNA Spikes for the ... for glass array printing and for protocol ... cDNA labeling, hybridization stringency and background. Normalize ... Spots and Oligo Spots, and complementary RNA ...
Biology Products: